02/12/2025
5:10 PM | Harmony Biosciences (Subject)
Valor IV Pharma Holdings, LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/05/2025
12:23 PM | BlackRock, Inc. (Filed by)
Harmony Biosciences (Subject)
| Form SCHEDULE 13G/A | |
01/30/2025
8:57 PM | Harmony Biosciences (Subject)
VANGUARD GROUP INC (Filed by)
| Form SCHEDULE 13G/A | |
01/28/2025
11:51 AM | Harmony Biosciences (Issuer)
Serafin Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
3:27 PM | Harmony Biosciences (Subject)
Kapadia Sandip (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/27/2025
3:27 PM | Dierks Jeffrey (Reporting)
Harmony Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/24/2025
3:18 PM | Dierks Jeffrey (Reporting)
Harmony Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2025
3:17 PM | Dayno Jeffrey M. (Reporting)
Harmony Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
3:15 PM | Harmony Biosciences (Issuer)
Kapadia Sandip (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/21/2025
7:44 PM | Dierks Jeffrey (Reporting)
Harmony Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/21/2025
3:20 PM | Dierks Jeffrey (Reporting)
Harmony Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for HRMY and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Harmony Biosciences and its competitors with MarketBeat's FREE daily newsletter. |
01/21/2025
3:21 PM | Dayno Jeffrey M. (Reporting)
Harmony Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/21/2025
3:21 PM | Harmony Biosciences (Subject)
Kapadia Sandip (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2025
3:30 PM | Dierks Jeffrey (Reporting)
Harmony Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2025
3:30 PM | Dierks Jeffrey (Reporting)
Harmony Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
3:26 PM | Dierks Jeffrey (Reporting)
Harmony Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
7:15 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2024
4:48 PM | Gracias Antonio J. (Reporting)
Harmony Biosciences (Issuer)
Sabater Juan A. (Reporting)
Valor Equity Associates IV L.P. (Reporting)
Valor Equity Capital IV LLC (Reporting)
VALOR EQUITY PARTNERS IV L.P. (Reporting)
VALOR EQUITY PARTNERS IV-A L.P. (Reporting)
VALOR EQUITY PARTNERS IV-B L.P. (Reporting)
Valor IV Pharma Holdings, LLC (Reporting)
Valor Management L.P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
3:05 PM | Harmony Biosciences (Issuer)
Marshman Fund Trust II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
3:06 PM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2024
3:39 PM | Harmony Biosciences (Filer)
| Form 424B7 | |
10/31/2024
3:45 PM | Dierks Jeffrey (Reporting)
Harmony Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/29/2024
4:27 PM | Harmony Biosciences (Filer)
| Form 424B7 | |
10/29/2024
3:22 PM | Dierks Jeffrey (Reporting)
Harmony Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/29/2024
7:00 AM | Harmony Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/29/2024
6:50 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2024
3:32 PM | Dierks Jeffrey (Reporting)
Harmony Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/01/2024
3:35 PM | Dierks Jeffrey (Reporting)
Harmony Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/01/2024
7:45 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/30/2024
3:28 PM | Dierks Jeffrey (Reporting)
Harmony Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/06/2024
7:00 AM | Harmony Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/31/2024
7:57 AM | Gracias Antonio J. (Reporting)
Harmony Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
7:58 AM | Harmony Biosciences (Issuer)
Sender Gary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
7:52 AM | Anastasiou Peter (Reporting)
Harmony Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
7:53 AM | Harmony Biosciences (Issuer)
Szyper Linda M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
7:54 AM | Harmony Biosciences (Issuer)
Nielsen Jack (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
7:54 AM | Graf R. Mark (Reporting)
Harmony Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
7:55 AM | Harmony Biosciences (Issuer)
Sabater Juan A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
4:01 PM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/03/2024
7:00 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/03/2024
7:05 AM | Budur Kumar (Reporting)
Harmony Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Why Buffett and 100 members of Congress are Piling into this One Investment (Ad) This isn't just another investment.
It might be the last retirement stock you'll ever need.
But this window of opportunity is closing fast. Click here for the ticker >>> |
04/30/2024
7:00 AM | Harmony Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/30/2024
6:45 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
8:44 AM | Harmony Biosciences (Filer)
| Form ARS | |
04/11/2024
7:30 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
7:17 AM | Harmony Biosciences (Filer)
| Form DEF 14A | |
04/11/2024
7:18 AM | Harmony Biosciences (Filer)
| Form DEFA14A | |
03/18/2024
6:24 PM | Dierks Jeffrey (Reporting)
Harmony Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
3:24 PM | Dierks Jeffrey (Reporting)
Harmony Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
4:17 PM | Dierks Jeffrey (Reporting)
Harmony Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
3:21 PM | Dierks Jeffrey (Reporting)
Harmony Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024
4:16 PM | Harmony Biosciences (Filer)
| Form 10-K/A | |
02/22/2024
7:00 AM | Harmony Biosciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/22/2024
6:45 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
